Skip to main content
CriticalFDAfda-F-1391-2024CHEMICAL EXPOSURE

ELV Control Herbal Supplement; 90 Capsules

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (chemical exposure). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
20,092
Recall Date
April 3, 2024
Issuing Agency
Hazard
Chemical Exposure

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1391-2024.

FDA Analysis found product labeled as tejocote is actually yellow oleander, which is toxic to humans.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1391-2024.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact World Green Nutrition Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1391-2024.

World Green Nutrition Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

World Green Nutrition Inc. Recall FAQ

World Green Nutrition Inc. is the subject of a supplements safety report: ELV Control Herbal Supplement; 90 Capsules. The notice was published on April 3, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 20,092 units are potentially affected.